AIG
TRIB

American International Group’s Trinity Biotech TRIB Stock Holding History

American International Group’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-736
Closed -$42K – 4344
2016
Q1 		$42K Buy
736
+1
+0.1% +$53 ﹤0.01% 3966
2015
Q4 		$43K Buy
735
+101
+16% +$5.96K ﹤0.01% 3988
2015
Q3 		$36K Buy
634
+141
+29% +$11.3K ﹤0.01% 4064
2015
Q2 		$44.5K Buy
493
+164
+50% +$14.2K ﹤0.01% 4086
2015
Q1 		$31.7K Buy
329
+83
+34% +$7.67K ﹤0.01% 4170
2014
Q4 		$21.6K Buy
246
+74
+43% +$6.38K ﹤0.01% 4307
2014
Q3 		$15.7K Buy
172
+82
+91% +$8.88K ﹤0.01% 4388
2014
Q2 		$10.4K Hold
90
– – ﹤0.01% 4478
2014
Q1 		$11K Sell
90
-608
-87% -$79.7K ﹤0.01% 4384
2013
Q4 		$87.7K Hold
698
– – ﹤0.01% 3440
2013
Q3 		$75.9K Sell
698
-307
-31% -$29.9K ﹤0.01% 3509
2013
Q2 		$84.7K Buy
+1,005
New +$83.4K ﹤0.01% 3266

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

American International Group's TRIB Position: Q2 2016 in Review

American International Group sold out of Trinity Biotech (TRIB) in Q2 2016, closing a stake of 736 shares — an estimated $42K sold.

American International Group first reported a position in TRIB in Q2 2013 and held it in 12 quarters. The position peaked at $87.7K in Q4 2013. 79 funds tracked by Wall St. Rank hold TRIB as of Q2 2016.

  • American International Group reported no remaining Trinity Biotech position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 736 Trinity Biotech shares in Q2 2016, an estimated $42K.
  • American International Group first reported a position in Trinity Biotech in Q2 2013 and held it in 12 quarters.
  • American International Group's Trinity Biotech position peaked at $87.7K in Q4 2013.
  • 79 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.